Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process

Table 2

Total antioxidative status/capacity (TAS/TAC), total oxidative status/capacity (TOS/TOC), and oxidative stress index (OSI) in the study group. Median values and interquartile range (1–3 Q).

	CD ()	CU ()	FGID (control group) ()	Statistical significance ( value)
BMI (kg/m^2)	20.1 (17.1–21.8)	18.9 (16.2–20.9)	18.4 (15.9–20.7)	0.4
IMC (cm)	0.4 (0.34–0.41)	0.43 (0.37–0.48)	0.405 (0.34–0.46)	0.2
TCH (mg/dl)	128.9 (111.2–142.5)	140.2 (116.7–160.7)	160.3 (131–185)	0.007
LDL (mg/dl)	68.2 (45.8–88.2)	73.8 (51.6–92.7)	93.2 (73.5–109.2)	0.009
HDL (mg/dl)	43.6 (−47.7)	49.1 (41–56.9)	50.0 (40.7–57.4)	0.1
TG (mg/dl)	84.9 (59–103)	90.5 (57–109)	85 (55–97)	0.7
Anti-oxLDL (U/ml)	8058 (207–7863)	6118 (242–7475)	4703 (842–7000)	0.7
oxLDL (ng/ml)	213.9 (12.8–167.9)	141.3 (17.5–182.4)	277.6 (15.8–379.1)	0.09
TAS/TAC (μmol/l)	270 (245–288)	262 (236–302)	262 (199–278)	0.4
Low (N (%))	22 (62.9%)	23 (63.9%)	23 (79.3%)	0.4
Moderate (N (%))	8 (22.8%)	9 (25%)	2 (6.9%)	0.4
High (N (%))	5 (14.3%)	4 (11.1%)	4 (13.8%)	0.4
TOS/TOC (μmol/l)	621 (373–1360)	853 (289–1899)	684 (428–1374)	0.9
Low (N (%))	5 (14.3%)	8 (22.2%)	2 (6.9%)	0.5
Mild (N (%))	3 (8.6%)	2 (5.5%)	2 (6.9%)	0.5
High (N (%))	27 (77.1%)	26 (72.3%)	25 (86.2%)	0.5
OSI	244 (131–513)	305 (115–755)	353 (161–534)	0.8